Magnetic field activated lipid-polymer hybrid nanoparticles for stimuli-responsive drug release.
about
Injectable PLGA/Fe3O4 implants carrying cisplatin for synergistic magnetic hyperthermal ablation of rabbit VX2 tumorSmart micro/nanoparticles in stimulus-responsive drug/gene delivery systems.Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.In situ formation of magnetopolymersomes via electroporation for MRI.Doxorubicin-loaded aromatic imine-contained amphiphilic branched star polymer micelles: synthesis, self-assembly, and drug delivery.Current advances in polymer-based nanotheranostics for cancer treatment and diagnosisBiomaterials for mRNA delivery.Triggered Release of Encapsulated Cargo from Photoresponsive Polyelectrolyte NanocomplexesLiposome-like Nanostructures for Drug Delivery.Merging the best of both worlds: hybrid lipid-enveloped matrix nanocomposites in drug delivery.Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery.Lipid-coated polymeric nanoparticles for cancer drug delivery.Ultra-small lipid-polymer hybrid nanoparticles for tumor-penetrating drug delivery.Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug ReleaseSynthesis, Functionalization, and Design of Magnetic Nanoparticles for Theranostic Applications.Layer-by-layer microcapsules for pH-controlled delivery of small moleculesDesign of hybrid nanovehicles for remotely triggered drug release: an overviewPreparation of particulate polymeric therapeutics for medical applications
P2860
Q30356500-CEECD927-577E-47CB-B7D9-1F922A23FA7CQ30361646-11EC5622-2A6F-405F-B6F3-20B0B0DD09A3Q30366990-860FC127-FB45-4981-8C21-3FD7F361F7E4Q30665894-D93B6E64-C016-4E37-89FC-46B7DAC69349Q30968289-CB960935-3FE6-4E9A-85FF-CEEB6AA15E8FQ34783018-5EF11DEA-CCA1-41FE-AB84-13F7F0FD61F7Q36271488-DDAFBB78-0656-423B-ADA9-8E46A6724396Q37260975-11377365-7DD0-41AC-9BE8-00C2B954C832Q37424654-4270FFEF-3D0F-4CA4-828A-94A46A0ED09EQ38150118-9D54C73E-68D5-413F-B2ED-5406B6B13CE5Q38252593-7D6522E9-18D8-44D6-AB7B-BEF3A2C4F963Q38556750-31008623-6D6F-48B0-B1EF-FCA74F90E754Q39605246-590D53DA-5967-48FA-BF5D-5E254ECBAF3EQ39929427-B69779CC-42DE-4E75-8B9F-98C5C92A0794Q47589446-A66B5400-70A0-4AFB-B222-E05C08A2BD3FQ57353636-664E2D8C-6079-430C-801E-73849E8D256EQ57366853-11112B32-B39C-490C-9177-D0973ABC32ABQ57498734-BE0B5DEC-46B8-4E6E-AC0A-B301789329A5
P2860
Magnetic field activated lipid-polymer hybrid nanoparticles for stimuli-responsive drug release.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Magnetic field activated lipid ...... imuli-responsive drug release.
@en
Magnetic field activated lipid ...... imuli-responsive drug release.
@nl
type
label
Magnetic field activated lipid ...... imuli-responsive drug release.
@en
Magnetic field activated lipid ...... imuli-responsive drug release.
@nl
prefLabel
Magnetic field activated lipid ...... imuli-responsive drug release.
@en
Magnetic field activated lipid ...... imuli-responsive drug release.
@nl
P2093
P2860
P1433
P1476
Magnetic field activated lipid ...... imuli-responsive drug release.
@en
P2093
Che-Ming Jack Hu
Liangfang Zhang
Marta Sartor
Seong Deok Kong
Sungho Jin
Weizhou Zhang
P2860
P304
P356
10.1016/J.ACTBIO.2012.11.006
P577
2012-11-10T00:00:00Z